Showing 15 posts of 253 posts found.

AstraZeneca’s Calquence approved in China for chronic lymphocytic leukaemia treatment

September 4, 2023
Medical Communications AstraZeneca, CLL, China, Oncology, SLL

AstraZeneca has announced that Calquence (acalabrutinib) has been approved in China for the treatment of adult patients with chronic lymphocytic …

AstraZeneca’s Forxiga approved in China for chronic heart failure treatment

August 18, 2023
Medical Communications AstraZeneca, Cardiology, China, cardiovascular, heart failure

AstraZeneca has announced that Forxiga (dapagliflozin) has been approved in China to reduce the risk of cardiovascular death, hospitalisation for …

Jacobio Pharma receives CDE approval for pancreatic cancer study in China

July 5, 2023
Medical Communications CDE, China, Jacobio Pharma, Oncology, Pancreatic cancer, clinical trial

Jacobio Pharma has announced that its novel KRAS G12C inhibitor glecirasib’s pivotal study for pancreatic cancer has been approved by …


AstraZeneca’s Xigduo XR approved in China for adults with type-2 diabetes

June 27, 2023
Medical Communications AstraZeneca, China, Diabetes, Xigduo XR, diabetes

AstraZeneca has announced that its Xigduo XR (dapagliflozin and metformin hydrochloride extended-release), a once-daily fixed-dose combination, has now been approved …

China rejects a second WHO probe into COVID outbreak origin

July 22, 2021
COVID-19, China

China has rejected WHO plans for a second investigation into the origin of the coronavirus pandemic, which includes the hypothesis …

Positive phase III results achieved for dialysis drug in China

April 30, 2021
Medical Communications China, Kideny disease

Vifor Fresenius Medical Care Renal Pharma (VFMCRP) today announced positive results from a phase-III study in China (PA-CL-CHINA-01), evaluating the …


UAE rolls out Sinopharm COVID-19 vaccine amid conflicting reports of efficacy

December 15, 2020
Manufacturing and Production, Research and Development COVID-19, China, Sinopharm, UAE, coronavirus

The United Arab Emirates has begun rolling out Sinopharm’s COVID-19 vaccine in its capital Abu Dhabi, despite claims that numerous …


China approves Takeda’s Takhzyro to prevent hereditary angioedema attacks in patients over 12

December 8, 2020
Manufacturing and Production, Sales and Marketing China, Takeda

China’s National Medical Products Administration (NMPA) has given approval in the country for Takeda’s Takhzyro (lanadelumab), in a subcutaneous injection …

China approves Astellas’ Xtandi in non-metastatic castration-resistant prostate cancer

November 6, 2020
Medical Communications, Sales and Marketing Astellas, China, NMPA, Xtandi

China’s drug regulator, the National Medical Products Administration (NMPA), has given the green light to Astellas to market Xtandi (enzalutamide …


Study that alleges COVID-19 was made in a Chinese lab originated from non-profits linked to ex-Trump advisor Steve Bannon

September 16, 2020
Research and Development China, Donald Trump, Steve Bannon, Wuhan, coronavirus

A new study that alleges COVID-19 was created in a Chinese lab was published by two non-profits that are linked …


China approves its first biosimilar of Roche’s Herceptin in HER2+ cancers

August 18, 2020
Manufacturing and Production, Sales and Marketing China, Henlius, Herceptin, Roche, biosimilar

China’s National Medical Products Administration (NMPA) has given the green light to Shanghai’s Henlius for its biosimilar version of Roche’s …


China’s drug regulator says vaccines must have 50 percent efficacy to be approved

August 17, 2020
Sales and Marketing COVID, China, coronavirus, vaccines

The Chinese Centre for Drug Evaluation (CCDE) has said that coronavirus vaccines must show 50 percent efficacy to be approved.  …


Gilead’s Truvada becomes first China-approved drug to prevent HIV-1

August 13, 2020
Sales and Marketing China, Truvada, approval. HIV

China’s National Medical Products Administration (NMPA) has awarded approval to Gilead’s Truvada in a pre-exposure prophylaxis (PrEP) indication to prevent …


AstraZeneca seals manufacturing deal to deliver COVID-19 vaccine in China

August 7, 2020
Manufacturing and Production, Medical Communications AstraZeneca, COVID-19, China, pharma

AstraZeneca has signed its first deal in China to produce and deliver its vaccine candidate against COVID-19 in the country, …


Eli Lilly teams up with Chi-Med for Chinese sales of Elunate capsules

July 28, 2020
Manufacturing and Production, Sales and Marketing Chi-Med, China, Eli Lilly

Eli Lilly Shanghai, an affiliate of the wider company, has enlisted the help of biopharma firm Hutchinson China MediTech, or …

Latest content